NEW DELHI: Bharat Biotech’s intranasal covid-19 vaccine iNCOVACC (BBV154) will be available for ₹325 per dose at government hospitals, and for ₹800 in private settings, the pharma major said on Tuesday
New Nasal Vaccine to Fight COVID-19: World s first intranasal vaccine for COVID-19, iNCOVACC (BBV154), gets approval from the Central Drugs Standard Control Organization (CDSCO).
Bharat Biotech International Limited (BBIL) announced that iNCOVACC (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO)
RSV, influenza, COVID-19 and monkeypox have dominated vaccine discussions this year, but vaccines are also being developed for a host of other infectious diseases.